Treatment of Rectal Cancer With Long-term Concurrent Chemoradiotherapy Combined With Camrelizumab
Status:
NOT_YET_RECRUITING
Trial end date:
2027-03-15
Target enrollment:
Participant gender:
Summary
This is a single-arm, phase II clinical study aim to evaluate the efficacy and safety of long-term concurrent chemoradiotherapy combined with camrelizumab as a neoadjuvant therapy in the treatment of locally advanced/low rectal cancer requiring anus preservation.
Phase:
PHASE2
Details
Lead Sponsor:
Harbin Medical University
Treatments:
camrelizumab Capecitabine Drug Therapy Radiotherapy